Unknown

Dataset Information

0

Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA.


ABSTRACT: As of March 2021, coronavirus disease (COVID-19) had led to >500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and chart-abstraction data during March 15‒August 15, 2020. Patients who died from COVID-19 were more likely to be older, male, and Black and to have underlying conditions (hereafter comorbidities) than case-patients who survived. We found 30.4% of surviving case-patients and 20.3% of deceased patients had no comorbidity information recorded. Chart-abstraction captured a higher proportion of deceased case-patients with >1 comorbidity (96.3%) compared with standard surveillance deaths (79.0%). Chart-abstraction detected higher rates of each comorbidity except for diabetes, which had similar rates among standard surveillance and chart-abstraction. Investing in public health data collection infrastructure will be beneficial for the COVID-19 pandemic and future disease outbreaks.

SUBMITTER: Parker JJ 

PROVIDER: S-EPMC8462317 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA.

Parker John James JJ   Octaria Rany R   Smith Miranda D MD   Chao Samantha J SJ   Davis Mary Beth MB   Goodson Celia C   Warkentin Jon J   Werner Denise D   Fill Mary-Margaret A MA  

Emerging infectious diseases 20211001 10


As of March 2021, coronavirus disease (COVID-19) had led to >500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and chart-abstraction data during March 15‒August 15, 2020. Patients who died from COVID-19 were more likely to be older, male, and Black and to have underlying conditions (hereafter comorbidities) than case-patients who survived. We found 30.4% of survivi  ...[more]

Similar Datasets

| S-EPMC4550146 | biostudies-literature
| S-EPMC8139232 | biostudies-literature
| S-EPMC8492161 | biostudies-literature
| S-EPMC8807315 | biostudies-literature
| S-EPMC7392471 | biostudies-literature
| S-EPMC5621543 | biostudies-literature
| S-EPMC4193168 | biostudies-literature
| S-EPMC2819870 | biostudies-literature
| S-EPMC5652434 | biostudies-literature
| S-EPMC10756380 | biostudies-literature